Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,618.00    4.00 (0.09%)
Bid:
4,626.00
Ask:
4,632.00
Spread: 6.00 (0.13%)
Market Cap: £2.15b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Directorship Changes

23 Nov 2023 07:00

RNS Number : 3776U
Morgan Sindall Group PLC
23 November 2023
 
Morgan Sindall Group plc

 

23 November 2023

 

Directorship changes

 

 

Morgan Sindall Group plc announces that Tracey Killen has notified the Board of her intention to step down as a non-executive director with effect from 31 December 2023. Jen Tippin will take over from Tracey as chair of the remuneration committee with effect from 7 December 2023.

 

Sharon Fennessy will join the Board as a non-executive director, with effect from 1 January 2024. Sharon will be a member of the nomination and audit committees and will take over as audit committee chair after the AGM in 2024.

 

Sharon is a highly accomplished FTSE financial leader with a strong track record of reporting standards at the highest level. She is currently non-executive director and member of the remuneration committee at Gowan Group Limited and non-executive director member of the audit and risk committee at John Lewis Partnership Limited. Sharon has strong strategic and commercial experience developed through her career at Diageo plc and in roles with Nortel Networks and Deloitte. 

 

Commenting on the changes, Michael Findlay, Chair of Morgan Sindall Group plc, said:

 

"I'd like to thank Tracey for her significant contribution to the Board over the last six years and wish her all the best for the future. I am delighted to welcome Sharon to the Board and look forward to working with her. Sharon brings extensive financial experience and strategic and commercial skills which will further broaden the expertise on the Board, adding valuable knowledge and insight to our discussions."

 

Ends

 

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to Sharon Rolston

 

Morgan Sindall Group plc is a leading UK Construction & Regeneration group with annual revenue of £3.6bn, employing around 7,600 employees and operating in the public, regulated and private sectors. It reports through six divisions of Construction, Infrastructure, Fit Out, Property Services, Partnership Housing and Urban Regeneration.

 

 

ENQUIRIES:

 

Morgan Sindall Group plc

Tel: 020 7307 9200

Michael Findlay, Chair

 

 

 

Brunswick

Tel: 020 7404 5959

 

Jonathan Glass

Nina Coad

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGUGGUPWGMP
Date   Source Headline
16th Jun 20251:55 pmRNSDirector/PDMR Shareholding
2nd Jun 20253:45 pmRNSTotal Voting Rights
2nd Jun 202511:14 amRNSCompany Secretary Change
8th May 20258:36 amRNSAdditional Listing
7th May 20252:30 pmRNSHolding(s) in Company
1st May 202512:42 pmRNSResult of AGM
1st May 20259:30 amRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Update
22nd Apr 20252:00 pmRNSCompany Secretary Change
22nd Apr 202510:11 amRNSBlock listing Interim Review
22nd Apr 20258:43 amRNSHolding(s) in Company
1st Apr 20259:38 amRNSTotal Voting Rights
27th Mar 20259:53 amRNSDirector/PDMR Shareholding
25th Mar 20251:50 pmRNSAdditional Listing
25th Mar 20257:00 amRNSTrading Update
24th Mar 20254:32 pmRNSHolding(s) in Company
20th Mar 20252:08 pmRNSAnnual Financial Report
14th Mar 202511:14 amRNSDirector/PDMR Shareholding
7th Mar 20251:33 pmRNSDirector/PDMR Shareholding
7th Mar 20251:26 pmRNSDirector/PDMR Shareholding
6th Mar 20254:42 pmRNSDirector/PDMR Shareholding
6th Mar 20254:38 pmRNSDirector/PDMR Shareholding
5th Mar 20258:56 amRNSDirector/PDMR Shareholding
3rd Mar 20259:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSResults for the Full Year Ended 31 December 2024
19th Feb 20253:20 pmRNSHolding(s) in Company
11th Feb 202512:00 pmRNSAppointment of Joint Corporate Broker
7th Feb 20252:37 pmRNSHolding(s) in Company
3rd Feb 202510:10 amRNSTotal Voting Rights
16th Jan 20257:07 amRNSDirector Declaration
16th Jan 20257:00 amRNSNotice of Full Year Results
15th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202511:56 amRNSTotal Voting Rights
20th Dec 20243:54 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:02 amRNSTotal Voting Rights
6th Nov 20241:18 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20244:17 pmRNSDirector/PDMR Shareholding
28th Oct 20249:24 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update and Outlook for 2024
21st Oct 20249:27 amRNSBlock listing Interim Review
15th Oct 202412:22 pmRNSAdditional Listing
1st Oct 202412:09 pmRNSTotal Voting Rights
27th Sep 20242:46 pmRNSDirector/PDMR Shareholding
10th Sep 202411:44 amRNSAdditional Listing
2nd Sep 202410:45 amRNSTotal Voting Rights
30th Aug 202410:35 amRNSHolding(s) in Company
30th Aug 20249:29 amRNSDirector/PDMR Shareholding
23rd Aug 20242:48 pmRNSDirector/PDMR Shareholding
12th Aug 20249:52 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.